Showing results (381-390 of 519) with videos related to
Sort By:
Pageof 52
Nature Neuroscience|February 24, 2006
Silencing of EphA3 through a cis interaction with ephrinA5Ricardo F Carvalho, Martin Beutler, Katharine J M Marler, et al.Pediatrics|February 5, 2002
Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 casesJennifer J Marler, Joshua B Rubin, Nikolaus S Trede, et al.Critical Care Medicine|August 1, 1989
Use of high dose naloxone in acute stroke: possible side-effectsW G Barsan, C P Olinger, H P Adams, et al.Gene Therapy|December 17, 2008
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivoM A Tyler, I V Ulasov, A M Sonabend, et al.Ultrasound in Medicine & Biology|July 6, 2012
Detection of progressive myocardial tissue injury by ultrasonic integrated backscatter immediately after coronary reperfusionMinako Katayama, Panupong Jiamsripong, Eileen M McMahon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cellsTze Wei Poh, Cathy S Madsen, Jessica E Gorman, et al.ACS Omega|January 19, 2026
Fundamental Properties of Low-Dimensional Perovskite-Related Light Absorbers: [(CH2)3NH2]3Sb2X9 (X = I, Br, Cl), Azetidinium Antimony HalidesYoung Un Jin, Bernd Marler, Andrei N Salak, et al.Alzheimer Disease and Associated Disorders|April 30, 2019
Dementia With Lewy Bodies: A Clinicopathologic Series of False-positive CasesLeonie J M Vergouw, Luca P Marler, Wilma D J van de Berg, et al.Neurology|April 23, 2003
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessmentB M Ravina, S C Fagan, R G Hart, et al.Stroke|September 1, 1990
Large-dose infusions of heparinoid ORG 10172 in ischemic strokeE W Massey, J Biller, J N Davis, et al.Pageof 52